Bruker Corp BRKR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Bruker Announces Date and Time of Third Quarter 2026 Earnings Release and Webcast
-
Untargeted timsTOF Mass Spectrometry Enables Discovery and Mapping of Draft Atlas of the Human Plasma Proteome at Proteoform Resolution
-
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research
-
Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
-
Bruker Corporation to Present at Upcoming Investor Conferences
-
BEST and Luvata Announce Collaboration Agreement for Supply of High-Performance RRP® Superconductors for Magnetic Confinement Fusion
-
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
-
Bruker Announces Majority Investment in MIMETAS to Advance Human Physiology-Relevant Drug Discovery and Development
Trading Information
- Previous Close Price
- $55.93
- Day Range
- $55.42–59.49
- 52-Week Range
- $32.37–66.98
- Bid/Ask
- $57.40 / $59.10
- Shares Outstanding
- 152.36M
- Market Cap
- $9.01B
- Volume/Avg
- 4M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 32.12
- Price/Sales
- 2.57
- Dividend Yield (Trailing)
- 0.34%
- Dividend Yield (Forward)
- 0.34%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 0.34%
Company Profile
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 11,085
- Website
- https://www.bruker.com
Valuation
|
Metric
|
BRKR
|
|---|---|
Price/Earnings (Normalized) | 32.12 |
Price/Book Value | 3.78 |
Price/Sales | 2.57 |
Price/Cash Flow | 22.18 |
Price/Earnings
BRKR
Financial Strength
|
Metric
|
BRKR
|
|---|---|
Quick Ratio | 0.83 |
Current Ratio | 1.85 |
Interest Coverage | 0.11 |
Quick Ratio
BRKR
Profitability
|
Metric
|
BRKR
|
|---|---|
Return on Assets (Normalized) | 4.69% |
Return on Equity (Normalized) | 12.70% |
Return on Invested Capital (Normalized) | 7.24% |
Return on Assets
BRKR
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|jP$kkl | LOCK|&qdf | $174B | |||
| Medtronic PLC
MDT
| LOCK|P@Q&!m | LOCK|d$v^ | $119B | |||
| Stryker Corp
SYK
| LOCK|@>$ZD?l$ | LOCK|<# | $114B | |||
| Boston Scientific Corp
BSX
| LOCK|B%!>jS | LOCK|lG^%t | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|ZJnl@JW | LOCK|y$!N | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|TfGptF | LOCK|H# | $31B | |||
| DexCom Inc
DXCM
| LOCK|f!NJr$@Y | LOCK|zJrL? | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|gcX | LOCK|Fj | $26B | |||
| Steris PLC
STE
| LOCK|&Hz%@HV | LOCK|&%wD% | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|s%P^kw>C | LOCK|^L | $18B |
United States